Cost of care for patients with rheumatoid arthritis receiving TNF-antagonist therapy using claims data

By Wu Eric   Chen Lei   Birnbaum Howard   Yang Elaine   Cifaldi Mary  

Current Medical Research and Opinion, Vol. 23, Iss. 8, 2007-08 ,pp. : 1749-1759

Informa Healthcare

Access to resources Recommend Favorite

Pharmacological treatment patterns among patients with attention-deficit/hyperactivity disorder: retrospective claims-based analysis of a managed care population

By Christensen Laura   Sasané Rahul   Hodgkins Paul   Harley Carolyn   Tetali Srinivas  

Current Medical Research and Opinion, Vol. 26, Iss. 4, 2010-04 ,pp. : 977-989

Informa Healthcare

Access to resources Recommend Favorite

Comparison of methods for measuring dose escalation of the subcutaneous TNF antagonists for rheumatoid arthritis patients treated in routine clinical practice

By Huang Xingyue   Gu Ning Yan   Fox Kathleen M.   Harrison David J.   Globe Denise  

Current Medical Research and Opinion, Vol. 26, Iss. 7, 2010-07 ,pp. : 1637-1645

Informa Healthcare

Access to resources Recommend Favorite

Anticoagulation therapy in patients with chronic atrial fibrillation: a retrospective claims data analysis

By Harley C.R.   Riedel A.A.   Hauch O.   Nelson M.   Wygant G.   Reynolds M.  

Current Medical Research and Opinion, Vol. 21, Iss. 2, 2005-02 ,pp. : 215-222

Informa Healthcare

Access to resources Recommend Favorite

The influence of TNF inhibitors on dementia incidence in patients with rheumatoid arthritis; an analysis from the BSRBR‐RA

By  

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, Vol. 33, Iss. 3, 2018-03 ,pp. : 556-558

John Wiley & Sons Inc

Access to resources Recommend Favorite